Article
Envision Pharma Group
Why Medical Affairs Needs More Leadership
Summary
In this episode, Scott Conry joins Tom Caravela to delve into the nuances of leadership within medical affairs. Scott shares his extensive experiences and challenges faced in leadership roles, offering insights into the development of essential leadership skills and building trust. The discussion covers tips for emerging leaders, the differences between in-house and outsourced leadership training, and fostering a leadership culture. Scott reflects on his journey, lessons learned from mistakes, and evolving trends in the field, emphasizing patient-centric leadership. The episode wraps up with closing thoughts and a preview of the next episode.
Today’s guest is Scott Conry, Vice President, Head Oncology Field Medical at GSK discusses why Medical Affairs needs more leadership.
Scott shares….
👉 What it takes to be a great leader
👉 Why there is a need for companies to develop people
👉 What people need to do to stand out and position themselves for growth
👉 How GOOD leaders unlock the potential of their team
👉 Thoughts on outsourcing leadership development
👉 What medical affairs needs to do to evolve
Medical Affairs Leadership, Leadership Development, Patient-Centric Leadership, Oncology Field Medical, Leadership Training
Related Topics
You May Also Like
Envision Pharma Group
Podcast
MSL Talk: Tom Caravela, Josh Kosnick
Soft Skills & Leadership Advice for Introverts: In an Extrovert World
Podcast
MSL Talk: Tom Caravela, Doug Yau
Emotional Intelligence and the MSL: More Important than EVER
Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS